Prior to joining NLO, I worked as an in-house patent attorney in a Belgian oncology-focused MDx company. Consequently, it is natural for me to think of my client’s strategy and needs. I believe that IP portfolios should be tailor-made and evolve dynamically in support of their owners’ business goals and arising opportunities.
Before that, I was a scientist primarily focused on molecular oncology. I hold a PhD in biotechnology from Ghent University and worked as a postdoctoral fellow at KUL. Therefore, my scientific expertise includes nucleic acid technologies such as amplification-based detection, sequencing, recombination, genetic engineering, genomics, transcriptomics, bioinformatics, but also proteomics, immunology, and biopharmaceuticals (antibodies, vaccines, cell-based therapies, etc.).
My approach to managing IP is pragmatic, practical, and goal-oriented. As a former researcher and an inventor on several patents, I am genuinely interested in science and technology. Consequently, I approach my clients’ inventions with great curiosity and enthusiasm. I value direct and honest interaction with my clients and strive to provide them with top-notch IP products in an efficient and adaptable manner.